Journal
BIOLOGY-BASEL
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/biology11030454
Keywords
glaucoma; diffusion; magnetic resonance imaging; visual pathway; eye; optic nerve
Categories
Funding
- National Institutes of Health [R01-EY028125]
- BrightFocus Foundation [G2013077, G2016030, G2019103]
- Glaucoma Foundation
- (Patricia Hill)-Research to Prevent Blindness Glaucoma Fellowship
- Feldstein Medical Foundation
- Research to Prevent Blindness
Ask authors/readers for more resources
This review summarizes the applications of advanced diffusion magnetic resonance imaging (MRI) in the glaucomatous visual system, discussing its potential in non-invasively evaluating glaucomatous changes and guiding early intervention. The review discusses various diffusion MRI methods used in visual system investigations, evaluating their ability to assess neuronal and glial integrity and comparing them with other imaging modalities. The review concludes that diffusion MRI holds promise in characterizing early glaucomatous changes, determining disease severity, and identifying potential neurotherapeutic targets.
Simple Summary This review summarizes current applications of advanced diffusion magnetic resonance imaging (MRI) throughout the glaucomatous visual system, focusing on the eye, optic nerve, optic tract, subcortical visual brain nuclei, optic radiations, and visual cortex. Glaucoma continues to be the leading cause of irreversible blindness worldwide and often remains undetected until later disease stages. The development of non-invasive methods for early detection of visual pathway integrity could pave the way for timely intervention and targeted treatment strategies. Principles of diffusion have been integrated with MRI protocols to produce a diffusion-weighted imaging modality for studying changes to tissue microstructures by quantifying the movement of water molecules in vivo. The development and applications of diffusion MRI in ophthalmology have allowed a better understanding of neural pathway changes in glaucoma. The feasibility of translating diffusion MRI techniques to assess both humans and experimental animal models of glaucoma and other optic neuropathies or neurodegenerative diseases is discussed. Recent research focuses on overcoming limitations in imaging quality, acquisition times, and biological interpretation suggest that diffusion MRI can provide an important tool for the non-invasive evaluation of glaucomatous changes in the visual system. Glaucoma is a group of ophthalmologic conditions characterized by progressive retinal ganglion cell death, optic nerve degeneration, and irreversible vision loss. While intraocular pressure is the only clinically modifiable risk factor, glaucoma may continue to progress at controlled intraocular pressure, indicating other major factors in contributing to the disease mechanisms. Recent studies demonstrated the feasibility of advanced diffusion magnetic resonance imaging (dMRI) in visualizing the microstructural integrity of the visual system, opening new possibilities for non-invasive characterization of glaucomatous brain changes for guiding earlier and targeted intervention besides intraocular pressure lowering. In this review, we discuss dMRI methods currently used in visual system investigations, focusing on the eye, optic nerve, optic tract, subcortical visual brain nuclei, optic radiations, and visual cortex. We evaluate how conventional diffusion tensor imaging, higher-order diffusion kurtosis imaging, and other extended dMRI techniques can assess the neuronal and glial integrity of the visual system in both humans and experimental animal models of glaucoma, among other optic neuropathies or neurodegenerative diseases. We also compare the pros and cons of these methods against other imaging modalities. A growing body of dMRI research indicates that this modality holds promise in characterizing early glaucomatous changes in the visual system, determining the disease severity, and identifying potential neurotherapeutic targets, offering more options to slow glaucoma progression and to reduce the prevalence of this world's leading cause of irreversible but preventable blindness.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available